Phase II Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Recurrent Glioblastoma
Phase of Trial: Phase II
Latest Information Update: 10 May 2017
At a glance
- Drugs Dianhydrogalactitol (Primary) ; Lomustine
- Indications Glioblastoma
- Focus Therapeutic Use
- Sponsors Del Mar Pharmaceuticals
- 05 Apr 2017 Trial design presented at the 108th Annual Meeting of the American Association for Cancer Research
- 05 Apr 2017 Trial design presented at the American Association for Cancer Research (AACR) Annual Meeting 2017, according to a Delmar Pharmaceuticals, Inc. media release.
- 13 Feb 2017 According to a DelMar Pharmaceuticals, media release, first patient has been dosed in the study.